Jerome de Seze

Jerome de Seze

UNVERIFIED PROFILE

Are you Jerome de Seze?   Register this Author

Register author
Jerome de Seze

Jerome de Seze

Publications by authors named "Jerome de Seze"

Are you Jerome de Seze?   Register this Author

100Publications

3668Reads

24Profile Views

Expert opinion: Criteria for second-line treatment failure in patients with multiple sclerosis.

Mult Scler Relat Disord 2019 Sep 19;36:101406. Epub 2019 Sep 19.

CHU de Montpellier, 191 Av. du Doyen Gaston Giraud, Montpellier, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.msard.2019.101406DOI Listing
September 2019

Emotional disturbances in multiple sclerosis: A neuropsychological and fMRI study.

Cortex 2019 Aug 1;117:205-216. Epub 2019 Mar 1.

University of Strasbourg and CNRS, ICube Laboratory UMR 7357 and FMTS (Fédération de Médecine Translationnelle de Strasbourg), Team IMIS/Neurocrypto, Strasbourg, France; University Hospitals of Strasbourg, CMRR (Memory Resources and Research Centre), Geriatric Day Hospital, Geriatrics Department, Strasbourg, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cortex.2019.02.017DOI Listing
August 2019

Long-term outcomes with teriflunomide in patients with clinically isolated syndrome: Results of the TOPIC extension study.

Mult Scler Relat Disord 2019 Aug 24;33:131-138. Epub 2019 May 24.

McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.msard.2019.05.014DOI Listing
August 2019

Serum-based differentiation between multiple sclerosis and amyotrophic lateral sclerosis by Random Forest classification of FTIR spectra.

Analyst 2019 Aug 1;144(15):4647-4652. Epub 2019 Jul 1.

Laboratory of Bioelectrochemistry and Spectroscopy, UMR 7140 University of Strasbourg/CNRS, 4 rue Blaise Pascal, 67000 Strasbourg, France. and University of Strasbourg Institute for Advanced Study (USIAS), Strasbourg, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1039/c9an00754gDOI Listing
August 2019

Comparative effectiveness of teriflunomide vs dimethyl fumarate in multiple sclerosis.

Neurology 2019 Aug 12;93(7):e635-e646. Epub 2019 Jul 12.

From INSERM (D.-A.L., L.B.), CIC 0004, Nantes; CRTI-INSERM UMR U1064 (D.-A.L.), Université de Nantes; Service de Neurologie (D.-A.L., S.W., L. Michel), CHU Nantes; Centre des Neurosciences de Lyon (R.C., F.R., S.V.), Observatoire Français de la Sclérose en Plaques, INSERM 1028 and CNRS UMR5292, Lyon; Université Claude Bernard Lyon 1 (R.C., F.R., S.V.), Université de Lyon; Department of Neurology (M.D.), Nancy University Hospital; Université de Lorraine (M.D.), EA 4360 APEMAC, Vandoeuvre-Lès-Nancy; Department of Neurology and Clinical Investigation Center (J.D.S.), CHU de Strasbourg, INSERM 1434; Department of Neurology (D.B.), CHU de Toulouse; Service de Neurologie (B. Brochet), CHU de Bordeaux; Service de Neurologie (J.P.), Hôpital de la Timone, CRMBM, CNRS, APHM, Aix Marseille Univ, Marseille; Univ Lille (P.V.), CHU Lille, LIRIC (Lille Inflammation Research International Center), INSERM UMR995; Service de Neurologie (G.E., L. Michel), CHU de Rennes; CRCSEP Nice (C.L.-F.), Neurologie Pasteur 2, Université Nice Cote d'Azur, Nice; Service de Neurologie (P. Clavelou), CHU de Clermont-Ferrand; Service de Neurologie (E.T.), CHU de Nîmes; Department of Neurology (J.-P.C.), Hôpital Nord, CHU Saint-Étienne; Service de Neurologie et Faculté de Médecine de Reims (A.T.), CHU de Reims, URCA; Service de Neurologie (B.S.), CHU Saint-Antoine; Service de Neurologie (A.A.K.), CHU d'Amiens; Service de Neurologie (P. Cabre), CHU de Fort de France; Service de Neurologie (C. Lubetzki, C.P.), CHU Pitié-Salpêtrière; Service de Neurologie (E.B.), CHU de Besançon; Service de Neurologie (O.H.), CH de Poissy; Service de Neurologie (T.D.), CH de Saint-Denis; Service de Neurologie (T.M.), CHU de Dijon; Service de Neurologie (O.G.), Fondation Rothschild; Service de Neurologie (B. Bourre), CHU de Rouen; Department of Neurology (A.W.), Hôpital Henri Mondor, Créteil; Service de Neurologie (P.L.), CHU de Montpellier; Service de Neurologie (L. Magy), CHU de Limoges; Service de Neurologie (G.D.), CHU de Caen; CRC SEP and Department of Neurology (A.-M.G.), CHU Bretonneau, Tours; Department of Neurology (N.M.), CHU La Milétrie, Poitiers; Department of Neurology (C. Labeyrie), CHU Bicêtre, Le Kremlin Bicêtre; Department of Neurology (I.P.), Hôpital Sud Francilien, Corbeil Essonnes; Department of Neurology (C.N.), CHU Versailles; Department of Neurology (O.C.), CHU de Grenoble; Ecole des Hautes Etudes en Santé Publique (E.L.), Rennes; Service de Neurologie, Sclérose en Plaques, Pathologies de la Myéline et Neuro-inflammation (S.V.), Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, Lyon/Bron; and INSERM (Y.F.), UMR 1246-SPHERE, Nantes University, Tours University, Nantes, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000007938DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6715507PMC
August 2019

Usefulness of MOG-antibody titres at first episode to predict the future clinical course in adults.

J Neurol 2019 Apr 3;266(4):806-815. Epub 2019 Jan 3.

Service de neurologie, sclérose en plaques, pathologies de la myéline et neuro-inflammation and Centre de référence pour les maladies inflammatoires rares du cerveau et de la moelle (MIRCEM), Hôpital Neurologique Pierre Wertheimer Hospices Civils de Lyon, 59 boulevard Pinel, BRON cedex, 69677, Lyon, France.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00415-018-9160-9
Publisher Site
http://dx.doi.org/10.1007/s00415-018-9160-9DOI Listing
April 2019

Correction to: Usefulness of MOG-antibody titres at first episode to predict the future clinical course in adults.

J Neurol 2019 Apr;266(4):816

Service de neurologie, sclérose en plaques, pathologies de la myéline et neuro-inflammation and Centre de référence pour les maladies inflammatoires rares du cerveau et de la moelle (MIRCEM), Hôpital Neurologique Pierre Wertheimer Hospices Civils de Lyon, 59 boulevard Pinel, BRON cedex, 69677, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00415-019-09215-1DOI Listing
April 2019

Neuraxial analgesia is not associated with an increased risk of post-partum relapses in MS.

Mult Scler 2019 04 20;25(4):591-600. Epub 2018 Mar 20.

Service de Neurologie A, Hôpital Pierre Wertheimer, Hospices Civils de Lyon, Lyon, France/Observatoire Français de la Sclérose en Plaques (OFSEP), Lyon, France/Centre de Recherche en Neurosciences de Lyon, INSERM U1028, CNRS UMR5292, Equipe Neuro-Oncologie et Neuro-Inflammation, Lyon, France/Université de Lyon 1, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458518763080DOI Listing
April 2019

FTY720 controls disease severity and attenuates sciatic nerve damage in chronic experimental autoimmune neuritis.

J Neuroinflammation 2019 Mar 2;16(1):54. Epub 2019 Mar 2.

Biopathologie de la Myéline, Neuroprotection et Stratégies Thérapeutiques, INSERM U1119/Université de Strasbourg, Faculté de Médecine, 11 rue Humann, 67085, Strasbourg, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12974-019-1441-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6397476PMC
March 2019

Myelin oligodendrocyte glycoprotein antibodies in neuromyelitis optica spectrum disorder.

Authors:
Jerome de Seze

Curr Opin Neurol 2019 02;32(1):111-114

CHU de Strasbourg, CIC 1434 INSERM, FMTS (federation de médecine translationnelle), Strasbourg University, Strasbourg, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/WCO.0000000000000650DOI Listing
February 2019

Ocrelizumab for the treatment of multiple sclerosis.

Expert Rev Neurother 2019 Feb 28;19(2):97-108. Epub 2018 Dec 28.

a Département de Neurologie , Centre Hospitalier Universitaire de Strasbourg, Avenue Moliére , 67200 Strasbourg , France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14737175.2019.1561284DOI Listing
February 2019

Multiple sclerosis with atypical MRI presentation: Results of a nationwide multicenter study in 57 consecutive cases.

Mult Scler Relat Disord 2019 Feb 18;28:109-116. Epub 2018 Dec 18.

MS Center and National Reference Center of adult Leukodystrophies, Department of Neurology, Montpellier University Hospital, 34 295 Montpellier Cedex 5, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.msard.2018.12.022DOI Listing
February 2019

Pharmacotherapy for Neuromyelitis Optica Spectrum Disorders: Current Management and Future Options.

Drugs 2019 Feb;79(2):125-142

Biopathologie de la Myéline, Neuroprotection et Stratégies Thérapeutiques, INSERM U1119, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Université de Strasbourg, Bâtiment 3 de la Faculté de Médecine, 11 rue Humann, 67000, Strasbourg, France.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s40265-018-1039-7
Publisher Site
http://dx.doi.org/10.1007/s40265-018-1039-7DOI Listing
February 2019

Benefits from an autobiographical memory facilitation programme in relapsing-remitting multiple sclerosis patients: a clinical and neuroimaging study.

Neuropsychol Rehabil 2018 Oct 9;28(7):1110-1130. Epub 2016 Oct 9.

a Cognitive Neuropsychology and Physiopathology of Schizophrenia (INSERM UMR 1114) , University of Strasbourg , Strasbourg , France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/09602011.2016.1240697DOI Listing
October 2018

Late activity rebound in non-active multiple sclerosis: A rare event.

Mult Scler 2018 10 13;24(12):1649-1650. Epub 2018 Mar 13.

1 Department of Neurology, Montpellier University Hospital, Montpellier, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458518765670DOI Listing
October 2018

The effect of oxysterols on nerve impulses.

Biochimie 2018 Oct 21;153:46-51. Epub 2018 Apr 21.

University of Bourgogne Franche-Comté, Team 'Biochemistry of the Peroxisome, Inflammation and Lipid Metabolism', EA 7270 / Inserm, Dijon, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.biochi.2018.04.013DOI Listing
October 2018

An autophagy-targeting peptide to treat chronic inflammatory demyelinating polyneuropathies.

J Autoimmun 2018 08 5;92:114-125. Epub 2018 Jun 5.

Fédération de Médecine Translationnelle de Strasbourg (FMTS), France; CNRS UMR7242 Biotechnology and Cell Signaling, University of Strasbourg, France /Laboratory of Excellence Medalis, France; University of Strasbourg Institute for Advanced Study (USIAS), Strasbourg, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaut.2018.05.009DOI Listing
August 2018

Testosterone and estrogen in multiple sclerosis: from pathophysiology to therapeutics.

Expert Rev Neurother 2018 06 6;18(6):515-522. Epub 2018 Jun 6.

d Departments of Neurology and Biomedicine , University Hospital Basel , Basel , Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14737175.2018.1481390DOI Listing
June 2018

Ozone, NO and PM are associated with the occurrence of multiple sclerosis relapses. Evidence from seasonal multi-pollutant analyses.

Environ Res 2018 05 6;163:43-52. Epub 2018 Feb 6.

METIS Department, EHESP French School of Public Health, Sorbonne Paris Cité, 15 avenue du Professeur 6 Léon-Bernard - CS 74312, 35043 Rennes, France; INSERM CIC-P 1414, CHU of Rennes, 2 Rue Henri le Guilloux, 35000 Rennes, France; EA 7449 REPERES, EHESP French School of Public Health, Sorbonne Paris Cité - University of Rennes 1, Rennes, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.envres.2018.01.040DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5886008PMC
May 2018

High-intensity interval training combined with resistance training improves physiological capacities, strength and quality of life in multiple sclerosis patients: a pilot study.

Eur J Phys Rehabil Med 2018 Feb 5;54(1):58-67. Epub 2017 Jul 5.

EA3072 Mitochondria, Oxidative Stress and Muscle Protection, Strasbourg University, Strasbourg, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.23736/S1973-9087.17.04637-8DOI Listing
February 2018

The translocator protein ligand XBD173 improves clinical symptoms and neuropathological markers in the SJL/J mouse model of multiple sclerosis.

Biochim Biophys Acta Mol Basis Dis 2017 12 9;1863(12):3016-3027. Epub 2017 Sep 9.

Biopathologie de la Myéline, Neuroprotection et Stratégies Thérapeutiques, INSERM U1119, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Université de Strasbourg, Bâtiment 3 de la Faculté de Médecine, 11 rue Humann, 67 000 Strasbourg, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbadis.2017.09.007DOI Listing
December 2017

MOG-antibody neuromyelitis optica spectrum disorder: is it a separate disease?

Authors:
Jérome de Seze

Brain 2017 12;140(12):3072-3075

University Hospital of Strasbourg, INSERM 1119 and INSERM 1434, FMTS, Strasbourg, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/brain/awx292DOI Listing
December 2017

Evidence of K homeostasis disruption in cellular dysfunction triggered by 7-ketocholesterol, 24S-hydroxycholesterol, and tetracosanoic acid (C24:0) in 158N murine oligodendrocytes.

Chem Phys Lipids 2017 10 18;207(Pt B):135-150. Epub 2017 Mar 18.

Univ Bourgogne Franche-Comté, Team 'Biochemistry of the Peroxisome, Inflammation and Lipid Metabolism' EA 7270/INSERM, Dijon, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.chemphyslip.2017.03.006DOI Listing
October 2017

Reversibility of the effects of natalizumab on peripheral immune cell dynamics in MS patients.

Neurology 2017 Oct 15;89(15):1584-1593. Epub 2017 Sep 15.

From Biogen (T.P., K.K.M., G.K., D.M., K.E., M.S., I.N., Y.C., Q.D., P.-R.H., D.A.), Cambridge, MA; Ashfield Healthcare Communications (A.A.), Middletown, CT; Hôpital Civil (J.D.S.), Strasbourg, France; Mellen Center for Multiple Sclerosis (R.F.), Cleveland Clinic, OH; St. Josef Hospital (R.G.), Ruhr University, Bochum, Germany; Piedmont HealthCare (D.J.), Mooresville, NC; Neurologic Clinic and Policlinic (L.K.), Departments of Medicine, Clinical Research, Biomedicine, and Biomedical Engineering, University Hospital and University of Basel, Switzerland; Vall d'Hebron University Hospital (X.M.), Barcelona, Spain; Jacobs MS Center and Pediatric MS Center of Excellence (B.W.-G.), Jacobs Neurological Institute, Buffalo, NY; Department of Neurology (H.-P.H.), Medical Faculty, Heinrich-Heine-University, Düsseldorf, Germany; and University of California San Francisco Multiple Sclerosis Center (B.A.C.C.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000004485DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5634662PMC
October 2017

Effectiveness of mycophenolate mofetil as first-line therapy in AQP4-IgG, MOG-IgG, and seronegative neuromyelitis optica spectrum disorders.

Mult Scler 2017 Sep 25;23(10):1377-1384. Epub 2016 Nov 25.

Service de Neurologie A and Eugène Devic EDMUS Foundation against Multiple Sclerosis, Observatoire Français de la Sclérose en Plaques (OFSEP), Hôpital Neurologique Pierre Wertheimer-GHE, Hospices Civils de Lyon, Bron, France/Lyon's Neuroscience Research Center, Team ONCOFLAM, Inserm U 1028/CNRS 5292, Lyon, France Université de Lyon, Université Claude Bernard Lyon 1, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458516678474DOI Listing
September 2017

Assessing Autophagy in Sciatic Nerves of a Rat Model that Develops Inflammatory Autoimmune Peripheral Neuropathies.

Cells 2017 Sep 18;6(3). Epub 2017 Sep 18.

CNRS UPR3572, Immunopathologie et Chimie Thérapeutique/Laboratory of excellence Medalis, Institut de Biologie Moléculaire et Cellulaire, 67000 Strasbourg, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cells6030030DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5617976PMC
September 2017

Autophagy in neuroinflammatory diseases.

Autoimmun Rev 2017 Aug 29;16(8):856-874. Epub 2017 May 29.

Immunopathology and therapeutic chemistry, UPR3572 CNRS, Laboratory of excellence Medalis, 67000 Strasbourg, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.autrev.2017.05.015DOI Listing
August 2017

Air pollution by particulate matter PM may trigger multiple sclerosis relapses.

Environ Res 2017 07 11;156:404-410. Epub 2017 Apr 11.

METIS Department, EA 7449 REPERES, EHESP French School of Public Health, Sorbonne Paris Cité, 15 avenue du Professeur Léon-Bernard - CS 74312, 35043 Rennes, France; INSERM CIC-P 1414, CHU of Rennes, 2 Rue Henri le Guilloux, 35000 Rennes, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.envres.2017.03.049DOI Listing
July 2017

Biotherapy in Inflammatory Diseases of the CNS: Current Knowledge and Applications.

Curr Treat Options Neurol 2017 May;19(5):19

Département de Neurologie, CHU de Strasbourg, Strasbourg, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11940-017-0456-3DOI Listing
May 2017

Natalizumab-PML survivors with subsequent MS treatment: Clinico-radiologic outcome.

Neurol Neuroimmunol Neuroinflamm 2017 May 14;4(3):e346. Epub 2017 Apr 14.

Department of Neurology (E.M., C. Louapre, C. Lubetzki, C.P.), Pitié-Salpêtrière Hospital, APHP, Paris; Department of Gerontology (J.-S.V.), Broca Hospital, APHP, Paris; Department of Neurology (D.B.), University Hospital of Toulouse; Department of Neurology (B.S.), Saint-Antoine Hospital, APHP, Paris; Department of Neurology (A.F., T.M.), University Hospital of Dijon; Department of Neurology (J.d.S.), University Hospital of Strasbourg; Department of Neurology (F.T., P.C.), University Hospital of Clermont-Ferrand; Department of Neurology (B.B.), University Hospital of Rouen, France; Department of Neurology (V.D.), University Hospital of Liège, Belgium; APHM (A.R., J.P.), Hôpital de la Timone, Pôle de Neurosciences Cliniques, Service de Neurologie, Marseille; Department of Neurology (P.L.), University Hospital of Montpellier; Department of Neurology (A.T.), University Hospital of Reims, URCA Reims, and LPN EA 2027 University Paris 8, Saint-Denis; and Department of Neurology (C. Lebrun), University Hospital of Nice, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/NXI.0000000000000346DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5462603PMC
May 2017

Exploratory Phase II Trial to Evaluate the Safety and the Antiepileptic Effect of Pitolisant (BF2.649) in Refractory Partial Seizures, Given as Adjunctive Treatment During 3 Months.

Clin Neuropharmacol 2016 Jul-Aug;39(4):188-93

*Clinical Center of investigation, INSERM U1434, University Hospital of Strasbourg, Strasbourg; †Neurology and Epileptology Department, Pierre Wertheimer University Hospital, Lyon; ‡Neurology Department, Albert Michallon University Hospital, Grenoble; §Neurology Department, University Hospital, Lille; ∥Neurology Department, Pontchaillou University Hospital, Rennes; ¶Bioprojet, Paris, France; and #Neurology Department, University Hospital of Strasbourg, Strasbourg, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/WNF.0000000000000159DOI Listing
January 2017

Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis.

N Engl J Med 2017 01 21;376(3):209-220. Epub 2016 Dec 21.

From Hospital Vall d'Hebron University, Barcelona (X.M.); University of California, San Francisco, San Francisco (S.L.H.), and Genentech, South San Francisco (D.M., H.G., P.C.) - both in California; University Hospital Basel, University of Basel (L.K.), and F. Hoffmann-La Roche (A.S., P.F., S.B., N.M.), Basel, Switzerland; McGill University (D.L.A., A.B.-O.) and NeuroRx Research (D.L.A.), Montreal, and University of British Columbia, Vancouver (A.T.) - both in Canada; University Vita-Salute San Raffaele, Milan (G.C.); University Hospital of Strasbourg, Clinical Investigation Center (INSERM Unité 1434), Fédération de Médecine Translationnelle de Strasbourg, Strasbourg, France (J.S.); Barts and the London School of Medicine and Dentistry, London (G.G.); Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf (H.-P.H.), and Technical University of Munich and Munich Cluster for Systems Neurology, Munich (B.H.) - both in Germany; Icahn School of Medicine at Mount Sinai, New York (F.L.); University of Miami, Miami (K.W.R.); Medical University of Łódź, Łódź, Poland (K.S.); and McGovern Medical School, University of Texas Health Science Center at Houston, Houston (J.S.W.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1606468DOI Listing
January 2017

CD62L test at 2 years of natalizumab predicts progressive multifocal leukoencephalopathy.

Neurology 2016 12 4;87(23):2491-2494. Epub 2016 Nov 4.

From the CHU Toulouse Purpan (B.P., F.B., D.B., D.A.-P., D.B.), Pôle Neurosciences; INSERM U1043-CNRS UMR 5282 (B.P., F.B., D.B.), Université Toulouse III, Centre de Physiopathologie Toulouse Purpan, France; University of Münster (N.S., T.S.-H., H.W.), Germany; University of Lille (O.O., H.Z., P.V.); Hôpital Civil (J.-C. Ongagna, J.d.S.), Strasbourg; CHU Pellegrin (B.B., J.-C. Ouallet), Bordeaux; CHU Nancy (M.D., S.P.); CHU Caen (G.D., N.D.); CH St Vincent (P.H.), GHICL, Lille; CHU Reims (A.T.); CHU Montpellier (P.L.); CHU Nîmes (G.C., W.C., O.C.); CHRU Clermont Ferrand (P.C.); CHU Besançon (E.B.); Aix Marseille University (J.P., A.R.), APHM, CHU Timone, Marseille; CHU Nantes (D.L., S.W.); CHU Grenoble (E.T.); CHU Dijon (T.M., A.F.); CHU Lyon (S.V.), Bron; Hôpital de la Salpêtrière (C.P.), Paris, France; Centre d'Esclerosi Múltiple de Catalunya (CEMCAT) (M.C.), Institut de Recerca Vall d'Hebron (VHIR), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Spain; and CHU Nice (C.L.-F.), France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000003401DOI Listing
December 2016

Giving meaning to illness: An investigation of self-defining memories in patients with relapsing-remitting multiple sclerosis patients.

Conscious Cogn 2016 10 19;45:200-209. Epub 2016 Sep 19.

Cognitive Neuropsychology and Physiopathology of Schizophrenia (INSERM U1114), Department of Psychiatry, University Hospital of Strasbourg, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.concog.2016.09.010DOI Listing
October 2016

False positivity of anti aquaporin-4 antibodies in natalizumab-treated patients.

Mult Scler 2016 08 11;22(9):1231-4. Epub 2016 Feb 11.

Department of Neurology, Hopital Pasteur, CHU de Nice, Nice, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458516630823DOI Listing
August 2016

Functional cerebral changes in multiple sclerosis patients during an autobiographical memory test.

Memory 2015 22;23(8):1123-39. Epub 2014 Sep 22.

a Cognitive Neuropsychology and Physiopathology of Schizophrenia (INSERM UMR 1114) , Strasbourg , France.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1080/09658211.2014.95
Publisher Site
http://dx.doi.org/10.1080/09658211.2014.955805DOI Listing
July 2016

Using mental visual imagery to improve autobiographical memory and episodic future thinking in relapsing-remitting multiple sclerosis patients: A randomised-controlled trial study.

Restor Neurol Neurosci 2015 ;33(5):621-38

Cognitive Neuropsychology and Physiopathology of Schizophrenia (INSERM UMR 1114), University of Strasbourg, Strasbourg, France.

View Article

Download full-text PDF

Source
http://www.medra.org/servlet/aliasResolver?alias=iospress&am
Publisher Site
http://dx.doi.org/10.3233/RNN-140461DOI Listing
July 2016

Neural correlates of episodic future thinking impairment in multiple sclerosis patients.

J Clin Exp Neuropsychol 2015 ;37(10):1107-23

a Cognitive Neuropsychology and Physiopathology of Schizophrenia (INSERM UMR 1114) , Strasbourg University , Strasbourg , France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/13803395.2015.1080228DOI Listing
June 2016

Functional and structural cerebral changes in key brain regions after a facilitation programme for episodic future thought in relapsing-remitting multiple sclerosis patients.

Brain Cogn 2016 06 2;105:34-45. Epub 2016 Apr 2.

Cognitive Neuropsychology and Physiopathology of Schizophrenia (INSERM UMR 1114), University of Strasbourg, Strasbourg, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bandc.2016.03.007DOI Listing
June 2016

Anti-pseudo-PCNA type 1 (anti-SG2NA) pattern: Track down Cancer, not SLE.

Joint Bone Spine 2016 May 1;83(3):330-4. Epub 2015 Oct 1.

Department of Clinical Immunology and Internal Medicine, National Reference Center for Autoimmune Diseases, Strasbourg Hospital and University, 1, place de l'Hôpital, 67091 Strasbourg, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jbspin.2015.07.002DOI Listing
May 2016

An update on the evidence for the efficacy and safety of rituximab in the management of neuromyelitis optica.

Ther Adv Neurol Disord 2016 May 23;9(3):180-8. Epub 2016 Mar 23.

Department of Neurology, Hôpital de Hautepierre, 1 avenue Molière, 67098, Strasbourg Cedex, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1756285616632653DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4811013PMC
May 2016

Teriflunomide in Patients with Relapsing-Remitting Forms of Multiple Sclerosis.

CNS Drugs 2016 Jan;30(1):41-51

Servei de Neurologia-Neuroimmunologia, Centre d'Esclerosi Múltiple de Catalunya, Cemcat, Hospital Universitari Vall d'Hebron, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40263-015-0299-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4733135PMC
January 2016

Update on biomarkers in neuromyelitis optica.

Neurol Neuroimmunol Neuroinflamm 2015 Aug 23;2(4):e134. Epub 2015 Jul 23.

Stanford University (E.M., M.H.H.), Stanford, CA; Johns Hopkins University (M.L.), Baltimore, MD; University of Oxford (P.J.W.), UK; Tohoku University (D.K.S.), Sendai, Japan; University of São Paulo (D.K.S.), Brazil; University of Colorado (J.L.B.), Denver; Mt. Sinai University (G.R.J.), New York, NY; Thomas Jefferson University (D.C.H.), Philadelphia, PA; IDIBAPS (A.S.), Barcelona, Spain; Montreal Neurological Institute and Hospital (A.B.-O.), McGill University, Montreal, Quebec, Canada; Research Institute and Hospital of National Cancer Center (H.J.K.), Goyang, Korea; KS Hegde Medical Academy (L.P.), Nitte University, Mangalore, India; Oxford University Hospital (M.I.L.), Oxford, UK; University of Southern Denmark (N.A.), Odense; Vejle Hospital (N.A.), Denmark; University Hospital (N.K.), Marrakech, Morocco; MS Center (R.H.), Erasmus MC University Medical Center, Rotterdam, the Netherlands; Service de Neurologie A (R.M.), Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, Bron, France; Molecular Neuroimmunology (S.J.), Department of Neurology, University Hospital Heidelberg, Germany; Tandem Labs (J.M.), San Diego, CA; University of Michigan Medical School (T.J.S.), Ann Arbor, MI; and David Geffen School of Medicine (M.R.Y.), University of California, Los Angeles.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/NXI.0000000000000134DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4516398PMC
August 2015

International consensus diagnostic criteria for neuromyelitis optica spectrum disorders.

Neurology 2015 Jul 19;85(2):177-89. Epub 2015 Jun 19.

From the Departments of Neurology (D.M.W.) and Library Services (K.E.W.), Mayo Clinic, Scottsdale, AZ; the Children's Hospital of Philadelphia (B.B.), PA; the Departments of Neurology and Ophthalmology (J.L.B.), University of Colorado Denver, Aurora; the Service de Neurologie (P.C.), Centre Hospitalier Universitaire de Fort de France, Fort-de-France, Martinique; Department of Neurology (W.C.), Sir Charles Gairdner Hospital, Perth, Australia; the Department of Neurology (T.C.), Massachusetts General Hospital, Boston; the Department of Neurology (J.d.S.), Strasbourg University, France; the Department of Multiple Sclerosis Therapeutics (K.F.), Tohoku University Graduate School of Medicine, Sendai, Japan; the Departments of Neurology and Neurotherapeutics (B.G.), University of Texas Southwestern Medical Center, Dallas; The Walton Centre NHS Trust (A.J.), Liverpool, UK; the Molecular Neuroimmunology Group, Department of Neurology (S.J.), University Hospital Heidelberg, Germany; the Center for Multiple Sclerosis Investigation (M.L.-P.), Federal University of Minas Gerais Medical School, Belo Horizonte, Brazil; the Department of Neurology (M.L.), Johns Hopkins University, Baltimore, MD; Portland VA Medical Center and Oregon Health and Sciences University (J.H.S.), Portland; the Department of Neurology (S.T.), National Pediatric Hospital Dr. Juan P. Garrahan, Buenos Aires, Argentina; the Department of Medicine (A.L.T.), University of British Columbia, Vancouver, Canada; Nuffield Department of Clinical Neurosciences (P.W.), University of Oxford, UK; and the Department of Neurology (B.G.W.), Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000001729DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4515040PMC
July 2015

Dalfampridine in hereditary spastic paraplegia: a prospective, open study.

J Neurol 2015 May 26;262(5):1285-8. Epub 2015 Mar 26.

Département de Neurologie, CHRU de Besançon, Besançon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00415-015-7707-6DOI Listing
May 2015

Challenges and opportunities in designing clinical trials for neuromyelitis optica.

Neurology 2015 Apr 3;84(17):1805-15. Epub 2015 Apr 3.

From the Department of Neurology (B.G.W.), Mayo Clinic, Rochester, MN; MedImmune Ltd. (G.B., A.F.), Riverside Building, Granta Park, Great Abington, Cambridge, UK; Guthy-Jackson Foundation (J.M.B., K.V.H.), San Diego, CA; Departments of Neurology and Ophthalmology (J.L.B.), University of Colorado Denver, Aurora; Novartis Pharmaceuticals Corporation (P.S.C.), East Hanover, NJ; Department of Neurology (B.A.C.C.), University of California San Francisco; CIC (Clinical Investigation Center) INSERM and UMR 1119 (J.d.S.), INSERM, Federation de Medecine Translationelle de Strasbourg, Université de Strasbourg; Department of Multiple Sclerosis Therapeutics (K.F.), Tohoku University, Sendai, Japan; Department of Neurology (B.G.), University of Texas Southwestern; Chugai Pharma USA (S.H., A.T.M.), Berkeley Heights, NJ; PPD Inc. (W.H.), Wilmington, NC; Department of Neurology (O.K.), Wayne State University, Detroit, MI; Teva Pharmaceuticals (V.K.), Frazer, PA; Department of Neurology (V.K.), Heinrich-Heine University, Dusseldorf, Germany; Department of Neurology (M.L.), Johns Hopkins University, Baltimore, MD; Department of Neurology (J.P.), Oxford University Hospital Trust, UK; Department of Ophthalmology and Visual Sciences (T.J.S.), Kellogg Eye Center, and Division of Metabolism, Endocrine, and Diabetes, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor; Department of Health Science (M.P.S.), University of Genoa, Italy; David Geffen School of Medicine at UCLA (K.V.H.), Los Angeles, CA; GlaxoSmithKline (S.V.), Research Triangle Park, NC; Center of Neuroimmunology (P.V.), Institute of Biomedical Research August Pi Sunyer (IDIBAPS)-Hospital Clinic Barcelona, Villarroel, Spain; United States Food and Drug Administration (M.K.W.), Center for Drug Evaluation and Research, Silver Spring, MD; Alexion Pharmaceuticals Inc. (W.W.), Cheshire, CT; Department of Neurology (D.M.W.), Mayo Clinic, Scottsdale, AZ; Department of Medicine (M.R.Y.), Divisions of M

View Article

Download full-text PDF

Source
http://www.neurology.org/content/84/17/1805.full.pdf
Web Search
http://www.neurology.org/cgi/doi/10.1212/WNL.000000000000152
Publisher Site
http://dx.doi.org/10.1212/WNL.0000000000001520DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4424131PMC
April 2015

Lyme neuroborreliosis and dementia.

J Alzheimers Dis 2014 ;41(4):1087-93

University Hospital of Strasbourg, Neuropsychology Unit, Neurology Service, Strasbourg, France INSERM U119, Strasbourg, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3233/JAD-130446DOI Listing
March 2015

MRI characteristics of neuromyelitis optica spectrum disorder: an international update.

Neurology 2015 Mar 18;84(11):1165-73. Epub 2015 Feb 18.

From the Department of Neurology (H.J.K., S.-H.K.), Research Institute and Hospital of National Cancer Center, Goyang, Korea; NeuroCure Clinical Research Center and Clinical and Experimental Multiple Sclerosis Research Center (F.P., J.W.), Department of Neurology, Charité University Medicine, Berlin, Germany; CIEM MS Research Center (M.A.L.-P.), Federal University of Minas Gerais Medical School, Belo Horizonte, Brazil; Department of Neurology (S.T.), National Paediatric Hospital Dr. Juan P. Garrahan, Buenos Aires, Argentina; Neurobiology (N.A.), Institute of Molecular Medicine, University of Southern Denmark; Department of Neurology (N.A.), Vejle Hospital, Denmark; Department of Clinical Neurology (J.P.), John Radcliffe Hospital, Oxford, UK; Department of Neurology, Massachusetts General Hospital (E.C.K.), Harvard Medical School, Boston, MA; Department of Neurology (D.K.S.), Tohoku University School of Medicine, Sendai, Japan; Neurology Department (J.d.S.), Hôpitaux Universitaires de Strasbourg, France; Institute of Neuroradiology (J.W.), University Medicine Goettingen, Germany; Department of Pediatrics (B.L.B.), Division of Neurology, The Children's Hospital of Philadelphia; Department of Neurology (B.L.B.), The University of Pennsylvania; Center of Neuroimmunology (P.V., A.S.), Service of Neurology, Hospital Clinic and Institute of Biomedical Research August Pi Sunyer, Barcelona, Spain; and Department of Multiple Sclerosis Therapeutics (K.F.), Tohoku University Graduate School of Medicine, Sendai, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000001367DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4371410PMC
March 2015

Adult-onset genetic leukoencephalopathies: a MRI pattern-based approach in a comprehensive study of 154 patients.

Brain 2015 Feb 19;138(Pt 2):284-92. Epub 2014 Dec 19.

1 Département de Neurologie, CHU de Montpellier, 34295 Montpellier, France

View Article

Download full-text PDF

Source
http://brain.oxfordjournals.org/content/brain/138/2/284.full
Web Search
http://www.brain.oxfordjournals.org/cgi/doi/10.1093/brain/aw
Publisher Site
http://dx.doi.org/10.1093/brain/awu353DOI Listing
February 2015

Characterization of a new rat model for chronic inflammatory demyelinating polyneuropathies.

J Neuroimmunol 2015 Jan 27;278:1-10. Epub 2014 Nov 27.

Biopathologie de la Myéline, Neuroprotection et Stratégies Thérapeutiques, INSERM U1119, Université de Strasbourg, Fédération de Médecine Translationnelle de Strasbourg, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jneuroim.2014.11.022DOI Listing
January 2015

Impaired mental simulation of specific past and future personal events in non-depressed multiple sclerosis patients.

J Neurol Sci 2014 Oct 10;345(1-2):68-74. Epub 2014 Jul 10.

Cognitive Neuropsychology and Physiopathology of Schizophrenia (INSERM U 1114), University of Strasbourg, Strasbourg, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jns.2014.07.007DOI Listing
October 2014

Relapsing optic neuritis: a multicentre study of 62 patients.

Mult Scler 2014 06 31;20(7):848-53. Epub 2013 Oct 31.

University Hospital, France Clinical Investigation Centre, INSERM 10002, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458513510223DOI Listing
June 2014

Chronic Bickerstaff's encephalitis with cognitive impairment, a reality?

BMC Neurol 2014 May 6;14:99. Epub 2014 May 6.

University Hospital of Strasbourg, Neuropsychology Unit, Neurology Service and CMRR (Centre Mémoire de Ressources et de Recherche), 1 avenue Molière, 67098 Strasbourg Cedex, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2377-14-99DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4040113PMC
May 2014

MS disease activity in RESTORE: a randomized 24-week natalizumab treatment interruption study.

Neurology 2014 Apr 28;82(17):1491-8. Epub 2014 Mar 28.

From the Mellen Center for Multiple Sclerosis (R.J.F.), Cleveland Clinic, OH; University of California San Francisco Multiple Sclerosis Center (B.A.C.C.); Hopital Civil (J.D.S.), Strasbourg, France; St. Josef Hospital (R.G.), Ruhr University, Bochum; Department of Neurology (H.-P.H.), Heinrich-Heine-University, Düsseldorf, Germany; The MS Center at Advance Neurology at Cornerstone Health Care (D.J.), Advance, NC; Departments of Neurology and Biomedicine (L.K.), University Hospital Basel, Switzerland; MS Center (M.K.), Carolinas Medical Center, Charlotte, NC; Vall d'Hebron University Hospital (X.M.), Barcelona, Spain; Jacobs MS Center and Pediatric MS Center of Excellence (B.W.-G.), Jacobs Neurological Institute, Buffalo, NY; Infusion Communications (B.A.), Haddam, CT; and Biogen Idec Inc. (A.N., B.T., P.D.), Weston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000000355DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4011468PMC
April 2014

A case of recurrent facial pain associated with a Pourfour du Petit syndrome: a new entity?

Headache 2014 Feb 23;54(2):373-7. Epub 2013 May 23.

Department of Neurology, Hôpital Universitaire de Strasbourg, Strasbourg, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/head.12137DOI Listing
February 2014

Immunological profiles determine neurological involvement in Sjögren's syndrome.

Eur J Intern Med 2014 Feb 29;25(2):177-81. Epub 2013 Oct 29.

Department of Internal Medicine, Limoges University Hospital, Limoges F-87042, France; EA 3842 - Department of Immunology, Limoges University, Limoges F-87042, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejim.2013.10.005DOI Listing
February 2014

No evidence for genetic association between glutamate transporter EAAT2 and Devic's neuromyelitis optica in caucasians and afro-caribbeans.

Mult Scler Relat Disord 2014 Jan 18;3(1):89-93. Epub 2013 Jul 18.

Caen University Hospital, Department of Neurology, Caen F-14000, France; INSERM U919, Serine Proteases and Pathophysiology of the Neurovascular Unit, GIP Cyceron, Université de Caen Basse-Normandie, Caen F-14000, France.. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.msard.2013.06.012DOI Listing
January 2014

Clinical spectrum and treatment of neuromyelitis optica spectrum disorders: evolution and current status.

Brain Pathol 2013 Nov;23(6):647-60

Department of Neurology, Tohoku University Graduate School of Medicine, Sendai, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bpa.12087DOI Listing
November 2013

Cognitive Dysfunction and Dementia in Primary Sjögren's Syndrome.

ISRN Neurol 2013 19;2013:501327. Epub 2013 Sep 19.

Neuropsychology Unit, Service of Neurology, University Hospital of Strasbourg, 1 avenue Molière, 67000 Strasbourg, France ; ICube Laboratory and Strasbourg Federation of Translational Medicine (FMTS), University of Strasbourg and CNRS, Strasbourg, France ; Memory Resource and Research Centre (CMRR) from Alsace, University Hospital of Strasbourg, 1 avenue Molière, 67000 Strasbourg, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2013/501327DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3793286PMC
November 2013

Novel advances in the diagnosis and treatment of neuromyelitis optica: is there a need to redefine the gold standard?

Expert Rev Clin Immunol 2013 Oct;9(10):979-86

Department of Neurology, Strasbourg University, Clinical Investigation Center and INSERM BMNST (UMR1119) Strasbourg Hospital, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/1744666X.2013.839944DOI Listing
October 2013

Evaluation of an albumin-binding gadolinium contrast agent in multiple sclerosis.

Neurology 2013 Jul 12;81(3):206-10. Epub 2013 Jun 12.

Service de Radiologie, Hôpital de Hautepierre, CHU de Strasbourg, Strasbourg, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0b013e31829bfdb9DOI Listing
July 2013

Inflammatory Optic Neuritis: From Multiple Sclerosis to Neuromyelitis Optica.

Authors:
Jérôme de Seze

Neuroophthalmology 2013 25;37(4):141-145. Epub 2013 Jul 25.

Departement de Neurologie, Hôpital Hautepierre CHU de Strasbourg, Strasbourg France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/01658107.2013.804232DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5291062PMC
July 2013